Why the study?
Type 2 myocardial infarctions are increasingly encountered and carry poor short- and long-term outcomes, highlighting the need for novel biomarker or imaging approaches for diagnosis and risk-stratification.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Type 2 myocardial infarctions are increasingly encountered and associated with poor outcomes, highlighting the need for novel diagnostic and risk-stratification approaches.
The diagnosis of T2MI requires biomarker evidence of acute myocardial injury and clear clinical evidence of acute myocardial ischemia without atherothrombosis. T2MIs are most often caused by noncoronary etiologies that alter myocardial oxygen supply and/or demand. They are increasingly encountered in clinical practice and associated with poor short- and long-term outcomes. Clinicians require novel biomarker or imaging approaches to facilitate diagnosis and risk-stratification.
No takes yet. Share an insight, caveat, or question.
Chapman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: